Metastatic Breast Cancer Clinical Trials in Chapel Hill, North Carolina
10 recruitingChapel Hill, North Carolina
Showing 1–10 of 10 trials
Recruiting
Phase 2
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Breast CancerMetastatic Breast Cancer
UNC Lineberger Comprehensive Cancer Center700 enrolled1 locationNCT07340541
Recruiting
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
Abramson Cancer Center at Penn Medicine200 enrolled37 locationsNCT06551116
Recruiting
Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Metastatic Breast Cancer
Memorial Sloan Kettering Cancer Center201 enrolled12 locationsNCT06099769
Recruiting
Not Applicable
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
Breast CancerMetastatic Breast Cancer
UNC Lineberger Comprehensive Cancer Center50 enrolled1 locationNCT07313306
Recruiting
Phase 2
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Metastatic Breast CancerHormone Receptor Positive HER-2 Negative Breast CancerRecurrent Breast Cancer
Puma Biotechnology, Inc.150 enrolled53 locationsNCT06369285
Recruiting
Phase 2
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Breast CancerMetastatic Breast CancerHER2-low Breast Cancer+1 more
Ana C Garrido-Castro, MD357 enrolled11 locationsNCT06533826
Recruiting
Not Applicable
Adaptation of a Values Assessment Tool
Metastatic Breast CancerCancer
UNC Lineberger Comprehensive Cancer Center40 enrolled1 locationNCT07068477
Recruiting
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
Metastatic Breast CancerEnd of Life
UNC Lineberger Comprehensive Cancer Center15 enrolled1 locationNCT05440929
Recruiting
Phase 1
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
Metastatic Breast CancerHER2-negative Breast Cancer
University of Texas Southwestern Medical Center30 enrolled7 locationsNCT05029999
Recruiting
Not Applicable
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
Breast CancerMetastatic Breast Cancer
UNC Lineberger Comprehensive Cancer Center120 enrolled2 locationsNCT06855654